Vivos (RDGL) Free Cash Flow Growth (5y) (2015 - 2025)
Vivos (RDGL) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.10% |
| Sep 30, 2025 | -20.04% |
| Jun 30, 2025 | -20.39% |
| Mar 31, 2025 | -39.15% |
| Dec 31, 2024 | -13.22% |
| Sep 30, 2024 | -22.31% |
| Jun 30, 2024 | -22.80% |
| Mar 31, 2024 | -5.28% |
| Dec 31, 2023 | 2.76% |
| Sep 30, 2023 | -25.62% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | -43.47% |
| Dec 31, 2022 | -11.45% |
| Sep 30, 2022 | 4.02% |
| Jun 30, 2022 | 19.34% |
| Mar 31, 2022 | -6.66% |
| Dec 31, 2021 | 41.95% |
| Sep 30, 2021 | -15.52% |
| Jun 30, 2021 | 17.58% |
| Mar 31, 2021 | 18.73% |